{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:09:24Z","timestamp":1759410564699},"reference-count":39,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"EuroTrans-Bio"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.vaccine.2016.09.057","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T18:01:08Z","timestamp":1476900068000},"page":"5968-5974","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media"],"prefix":"10.1016","volume":"34","author":[{"given":"Marrit N.","family":"Habets","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"van Selm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred J.","family":"van Opzeeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elles","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.M.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri A.","family":"Diavatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.09.057_b0005","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.vaccine.2005.01.023","article-title":"Bacterial otitis media: a vaccine preventable disease?","volume":"23","author":"Cripps","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.057_b0010","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.5694\/j.1326-5377.2009.tb02926.x","article-title":"Otitis media: viruses, bacteria, biofilms and vaccines","volume":"191","author":"Massa","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.09.057_b0015","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine","volume":"29","author":"Casey","year":"2010","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.09.057_b0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/INF.0000000000000536","article-title":"Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era","volume":"34","author":"Tamir","year":"2015","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.09.057_b0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001480.pub4","article-title":"Pneumococcal conjugate vaccines for preventing otitis media","author":"Fortanier Alexandre","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.09.057_b0030","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.057_b0035","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0040","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4(+) T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.09.057_b0045","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/IAI.01379-10","article-title":"Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study","volume":"79","author":"Lebon","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.057_b0050","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1073\/pnas.1121383109","article-title":"Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity","volume":"109","author":"Malley","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2016.09.057_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.057_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003274","article-title":"Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung","volume":"9","author":"Wright","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2016.09.057_b0065","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/mi.2014.55","article-title":"Antibody blocks acquisition of bacterial colonization through agglutination","volume":"8","author":"Roche","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2016.09.057_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/jir340","article-title":"Reduced memory CD4(+) T-cell generation in the circulation of young children may contribute to the otitis-prone condition","volume":"204","author":"Sharma","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0075","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.vaccine.2009.03.055","article-title":"Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice","volume":"27","author":"Oma","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.057_b0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1086\/509807","article-title":"Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection","volume":"195","author":"Hanniffy","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0085","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.vaccine.2015.03.010","article-title":"Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization","volume":"33","author":"Kuipers","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.057_b0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/IAI.01278-12","article-title":"Influenza-induced inflammation drives pneumococcal otitis media","volume":"81","author":"Short","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.057_b0095","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/infdis\/jir618","article-title":"Influenza virus induces bacterial and nonbacterial otitis media","volume":"204","author":"Short","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0100","first-page":"2357","article-title":"Using bioluminescent imaging to investigate synergism between Streptococcus pneumoniae and influenza A virus in infant mice","volume":"14","author":"Short","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2016.09.057_b0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0110","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.192.2.271","article-title":"B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection","volume":"192","author":"Baumgarth","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.057_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20071168","article-title":"Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies","volume":"205","author":"Giefing","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.057_b0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung Cxc chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.09.057_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00079-12","article-title":"Modified lipooligosaccharide structure protects nontypeable Haemophilus influenzae from IgM-mediated complement killing in experimental otitis media","volume":"3","author":"Langereis","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2016.09.057_b0130","doi-asserted-by":"crossref","first-page":"e5190","DOI":"10.1371\/journal.pone.0005190","article-title":"Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens","volume":"4","author":"Lee","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.09.057_b0135","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/eji.201040997","article-title":"Intradermal immunization in the ear with cholera toxin and its non-toxic beta subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs","volume":"41","author":"Meza-Sanchez","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.09.057_b0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/350423a0","article-title":"A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin [mu] chain gene","volume":"350","author":"Kitamura","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.09.057_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3181\/0809-RM-269","article-title":"Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae","volume":"234","author":"Shah","year":"2009","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.vaccine.2016.09.057_b0150","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.vaccine.2010.12.117","article-title":"Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice","volume":"29","author":"Ezoe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.09.057_b0155","doi-asserted-by":"crossref","first-page":"e0140112","DOI":"10.1371\/journal.pone.0140112","article-title":"Clinical and microbiological mactors associated with high nasopharyngeal pneumococcal density in patients with pneumococcal pneumonia","volume":"10","author":"Alpkvist","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.09.057_b0160","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1093\/infdis\/jiu326","article-title":"High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia","volume":"210","author":"Wolter","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.09.057_b0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-8244(03)00108-1","article-title":"Protective efficacy of PspA (pneumococcal surface protein A)-based DNA vaccines: contribution of both humoral and cellular immune responses","volume":"37","author":"Miyaji","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2016.09.057_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fc\u03b3 receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2016.09.057_b0175","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0161-5890(84)90103-2","article-title":"Binding of complement subcomponent C1q to mouse IgG1, IgG2a and IgG2b: a novel C1q binding assay","volume":"21","author":"Leatherbarrow","year":"1984","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2016.09.057_b0180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1128\/IAI.01012-09","article-title":"Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B\/C2","volume":"78","author":"Tong","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.057_b0185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/IAI.01104-13","article-title":"Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media","volume":"82","author":"Short","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.09.057_b0190","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/INF.0b013e31821c2d8b","article-title":"Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children","volume":"30","author":"Kaur","year":"2011","journal-title":"Pediat Infect Dis J"},{"key":"10.1016\/j.vaccine.2016.09.057_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/emmm.201202150","article-title":"A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media","volume":"6","author":"Rosch","year":"2014","journal-title":"EMBO Mol Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630891X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630891X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T19:20:21Z","timestamp":1657480821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630891X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":39,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0264410X1630891X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of antibodies and IL17-mediated immunity in protection against pneumococcal otitis media","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}